Epstein Secrets

House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, induding Moderna, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios (5/5, Baker, 1.26M) says a waiver "would open the door for foreign manufact

Virtual Event; 10:15 AM • House Science subcommittee latest hearing on the NSF (virtual) - Research and Technology Subcommittee virtual hearing on 'National Science Foundation: Advancing Research for the Future of U.S. Innovation Part II', held via Zoom, with testimony from University of California- Los Angeles Vice Chance

House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, including Modema, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios (5/5, Baker, 1.26M) says a waiver "would open the door for foreign manufac

Virtual Event; 10:15 AM • House Science subcommittee latest hearing on the NSF (virtual) - Research and Technology Subcommittee virtual hearing on 'National Science Foundation: Advancing Research for the Future of U.S. Innovation Part II, held via Zoom, with testimony from University of California-Los Angeles Vice Chancel

Development Head for Pfizer Neuroscience, as well as Worldwide Head of Clinical Research and Development. Additional positions during his 12 years at Pfizer included Vice President of Exploratory Development for the Mid West region, and Head of Experimental Medicine at Pfizer’s Sandwich, UK Laboratories.

er at Novartis Institutes for BioMedical Research (2004-2007). Mark received his Ph.D. in Chemistry and Chemical Biology from Harvard University as a National Science Foundation Graduate Research Fellow. Mike Dybbs, Ph.D., (39), Principal, joined New Leaf in 2009 and was promoted to Principal in 2012. Mike is currently on th